Pacer Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.12M | Sell |
|
|||||
|
2025
Q2 | $9.09M | Sell |
|
|||||
|
2025
Q1 | $13.2M | Sell |
|
|||||
|
2024
Q4 | $57.8M | Sell |
|
|||||
|
2024
Q3 | $54.7M | Buy |
|
|||||
|
2024
Q2 | $36.1M | Buy |
|
|||||
|
2024
Q1 | $45.9K | Buy |
|
|||||
|
2023
Q4 | $18.2K | Buy |
|
|||||
|
2023
Q3 | $8.35K | Sell |
|
|||||
|
2023
Q2 | $13.5M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $9.89M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.42M | Sell |
|
|||||
|
2021
Q2 | $2.96M | Buy |
|
|||||
|
2021
Q1 | $1.45M | Buy |
|
|||||
|
2020
Q4 | $465K | Buy |
|
|||||
|
2020
Q3 | $321K | Buy |
|
|||||
|
2020
Q2 | $190K | Sell |
|
|||||
|
2020
Q1 | $201K | Sell |
|
|||||
|
2019
Q4 | $495K | Sell |
|
|||||
|
2019
Q3 | $640K | Buy |
|
|||||
|
2019
Q2 | $539K | Buy |
|
|||||
|
2019
Q1 | $493K | Buy |
|
|||||
|
2018
Q4 | $397K | Buy |
|